Morphea
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
Ọnya Morphea na-apụtakarị dị ka patch nwere pigmenti atrophic.
References
Scleroderma bụ ọrịa na-adịghị ahụkebe na-emetụta anụ ahụ njikọ, na-egosi dị ka akpụkpọ anụ siri ike na mgbe ụfọdụ na-emetụta akụkụ ahụ ndị ọzọ. E nwere ụdị isi abụọ: systemic sclerosis , nke gụnyere ime ka akpụkpọ anụ na akụkụ ahụ dị n'ime ya, yana localized scleroderma , nke a makwaara dị ka morphea, nke na-anọkarị naanị akpụkpọ na anụ ahụ dị n'okpuru ya, na-enwe usoro na-adịghị mma na nke na-egbochi onwe ya. Ọ bụ ezie na scleroderma na mpaghara ebe a na-adịghị ahụkebe na ihe kpatara ya amabeghị, nchọpụta na-adịbeghị anya na-egosi na ọ nwekwara ike imetụta akụkụ ahụ dị n'ime ma bute nsogbu ahụike dị iche iche. Ọgwụgwọ n'oge dị oke mkpa iji gbochie nsogbu, n'ihi na enwere ike ịdị njọ nke localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Morphea , nke a makwaara dị ka scleroderma mpaghara, bụ ọrịa autoimmune na-adịghị ahụkebe na-emetụta anụ ahụ njikọ. Ọ nwere ike igosipụta n'ụzọ dị iche iche, ọ bụghịkwa ihe a na-ahụkarị, yana ihe dị ka 0. 4 - 2. 7 ikpe kwa 100,000 mmadụ kwa afọ. A na-ahụkarị Morphea na ụmụaka nọ n'agbata afọ 2 na 14, ọ na-emetụtakarị ụmụ agbọghọ karịa ụmụ nwoke.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea bụ ọrịa na-adịghị ahụkebe. N'ihi nhazi nke foto a, algọridim nwere ike imehie ya maka morphea.